Brief: Hookipa Pharma Entered Registration Rights Agreement With Gilead Sciences
22/06/2022 11:46
June 22 (Reuters) - Gilead Sciences Inc GILD.O :
* HOOKIPA PHARMA INC - ON JUNE 17, ENTERED INTO A
REGISTRATION
RIGHTS AGREEMENT WITH GILEAD SCIENCES, INC.
* HOOKIPA - PURSUANT TO STOCK PURCHASE AGREEMENT, GILEAD IS
REQUIRED, AT COMPANY'S OPTION, TO BUY UP TO $35 MILLION OF CO'S
COMMON STOCK
* HOOKIPA- PURSUANT TO TERMS OF REGISTRATION RIGHTS
AGREEMENT,
AGREED TO FILE REGISTRATION STATEMENT COVERING RESALE OF INITIAL
SHARES BY NO LATER THAN AUG 15
Source text for Eikon: [https://bit.ly/3QDh7WO]
Further company coverage: GILD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)